Skip to Main Content
Don't have an account? Create Account

Association Comments on Proposed 340B Acquisition Cost Collection

In a Nov. 27 letter to the Centers for Medicare & Medicaid Services (CMS) Office of Strategic Operations and Regulatory Affairs, America’s Essential Hospitals expressed concern that a proposed drug acquisition cost survey would impose excessive burden on hospitals in the 340B Drug Pricing Program and would raise many operational challenges.

The letter was sent in response to a notice announcing that CMS plans to develop and distribute a survey to collect acquisition cost data from hospitals participating in the 340B program.

In its comments, the association asserts that the proposed collection exceeds CMS’ authority under  Medicare statute and emphasized the administrative burden such a survey would place on essential hospitals. The association urged CMS not to implement the proposed collection without fully considering the impact it will have on 340B hospitals.

Contact Senior Director of Policy Erin O’Malley at eomalley@essentialhospitals.org or 202.585.0127 with questions.

Share

About the Author

Rachel Schwartz is a policy associate at America's Essential Hospitals.

Previous Next
Close
Test Caption
Test Description goes like this